Total Payments
$118,334
2024 Payments
$5,800
Companies
12
Transactions
184
Medicare Patients
2,097
Medicare Billing
$126,693
Payment Breakdown by Category
Other$93,385 (78.9%)
Travel$13,226 (11.2%)
Food & Beverage$7,174 (6.1%)
Consulting$4,516 (3.8%)
Education$32.37 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $93,385 | 47 | 78.9% |
| Travel and Lodging | $13,226 | 76 | 11.2% |
| Food and Beverage | $7,174 | 54 | 6.1% |
| Consulting Fee | $4,516 | 3 | 3.8% |
| Education | $32.37 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Duchesnay USA Incorporated | $57,729 | 88 | $0 (2019) |
| AMAG Pharmaceuticals, Inc. | $35,868 | 62 | $0 (2018) |
| Astellas Pharma US Inc | $21,661 | 19 | $0 (2024) |
| SCYNEXIS, Inc. | $2,444 | 3 | $0 (2022) |
| Hologic, LLC | $274.98 | 3 | $0 (2018) |
| Lupin Inc. | $118.73 | 1 | $0 (2019) |
| Myriad Women's Health, Inc. | $96.77 | 1 | $0 (2023) |
| Celularity Inc. | $50.00 | 1 | $0 (2021) |
| Vertical Pharmaceuticals, LLC | $35.88 | 2 | $0 (2017) |
| Avion Pharmaceuticals | $27.00 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,800 | 6 | Astellas Pharma US Inc ($5,800) |
| 2023 | $15,957 | 14 | Astellas Pharma US Inc ($15,861) |
| 2022 | $2,461 | 4 | SCYNEXIS, Inc. ($2,444) |
| 2021 | $50.00 | 1 | Celularity Inc. ($50.00) |
| 2019 | $1,777 | 5 | Duchesnay USA Incorporated ($1,658) |
| 2018 | $41,021 | 72 | Duchesnay USA Incorporated ($34,395) |
| 2017 | $51,268 | 82 | AMAG Pharmaceuticals, Inc. ($29,443) |
All Payment Transactions
184 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $515.00 | General |
| Category: Biological | ||||||
| 04/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,575.00 | General |
| Category: Biological | ||||||
| 04/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $122.44 | General |
| Category: Biological | ||||||
| 04/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $5.01 | General |
| Category: Biological | ||||||
| 04/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,575.00 | General |
| Category: Biological | ||||||
| 04/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $8.04 | General |
| Category: Biological | ||||||
| 12/11/2023 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,575.00 | General |
| Category: Biological | ||||||
| 12/11/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Biological | ||||||
| 12/11/2023 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $13.48 | General |
| Category: Biological | ||||||
| 11/14/2023 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,575.00 | General |
| Category: Biological | ||||||
| 11/14/2023 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $37.79 | General |
| Category: Biological | ||||||
| 11/14/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Biological | ||||||
| 08/09/2023 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,805.00 | General |
| Category: Biological | ||||||
| 08/09/2023 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $36.14 | General |
| Category: Biological | ||||||
| 08/09/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Biological | ||||||
| 08/09/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Biological | ||||||
| 06/20/2023 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,545.00 | General |
| Category: Biological | ||||||
| 06/01/2023 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,120.00 | General |
| Category: Biological | ||||||
| 04/25/2023 | Myriad Women's Health, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $96.77 | General |
| Category: ONCOLOGY | ||||||
| 01/11/2023 | Astellas Pharma US Inc | — | Consulting Fee | Cash or cash equivalent | $2,965.00 | General |
| 07/29/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Education | In-kind items and services | $16.35 | General |
| Category: HORMONE THERAPY | ||||||
| 06/14/2022 | SCYNEXIS, Inc. | — | Food and Beverage | In-kind items and services | $6.37 | General |
| 03/27/2022 | SCYNEXIS, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 02/18/2022 | SCYNEXIS, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,038.00 | General |
| 09/02/2021 | Celularity Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $50.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 386 | 427 | $77,360 | $27,942 |
| 2022 | 13 | 545 | 611 | $99,330 | $35,109 |
| 2021 | 14 | 663 | 742 | $106,538 | $36,794 |
| 2020 | 13 | 503 | 544 | $85,715 | $26,848 |
Total Patients
2,097
Total Services
2,324
Medicare Billing
$126,693
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 64 | $16,000 | $7,376 | 46.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 44 | $8,360 | $3,531 | 42.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 34 | 53 | $5,300 | $2,615 | 49.3% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 18 | 22 | $9,350 | $2,486 | 26.6% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 18 | 22 | $9,350 | $2,222 | 23.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $4,200 | $1,956 | 46.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 40 | 40 | $8,000 | $1,892 | 23.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 36 | 36 | $3,600 | $1,826 | 50.7% |
| 87491 | Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | Office | 2023 | 50 | 50 | $5,000 | $1,720 | 34.4% |
| 87591 | Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique | Office | 2023 | 48 | 48 | $4,800 | $1,651 | 34.4% |
| 87480 | Detection test for candida species (yeast), direct probe technique | Office | 2023 | 17 | 17 | $1,700 | $334.05 | 19.7% |
| 87510 | Detection test for gardnerella vaginalis (bacteria), direct probe technique | Office | 2023 | 17 | 17 | $1,700 | $334.05 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 60 | $15,161 | $6,627 | 43.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 68 | $13,007 | $5,624 | 43.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 55 | 55 | $5,577 | $2,903 | 52.1% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 23 | 24 | $10,200 | $2,856 | 28.0% |
| 87491 | Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | Office | 2022 | 73 | 80 | $8,000 | $2,770 | 34.6% |
| 87591 | Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique | Office | 2022 | 73 | 80 | $8,000 | $2,770 | 34.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 55 | 55 | $10,950 | $2,734 | 25.0% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 22 | 22 | $9,350 | $2,307 | 24.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 29 | 42 | $4,280 | $2,237 | 52.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $4,200 | $2,143 | 51.0% |
| 87480 | Detection test for candida species (yeast), direct probe technique | Office | 2022 | 44 | 50 | $5,000 | $990.10 | 19.8% |
| 87510 | Detection test for gardnerella vaginalis (bacteria), direct probe technique | Office | 2022 | 44 | 50 | $5,000 | $990.10 | 19.8% |
| 82746 | Folic acid level, serum | Office | 2022 | 11 | 11 | $605.00 | $159.93 | 26.4% |
About Dr. Mark Defazio, MD
Dr. Mark Defazio, MD is a Obstetrics & Gynecology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073586343.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Defazio, MD has received a total of $118,334 in payments from pharmaceutical and medical device companies, with $5,800 received in 2024. These payments were reported across 184 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($93,385).
As a Medicare-enrolled provider, Defazio has provided services to 2,097 Medicare beneficiaries, totaling 2,324 services with total Medicare billing of $126,693. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Brooklyn, NY
- Active Since 02/08/2006
- Last Updated 09/23/2011
- Taxonomy Code 207V00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1073586343
Products in Payments
- Osphena (Drug) $41,084
- Veozah (Drug) $18,696
- Diclegis (Drug) $16,645
- INTRAROSA (Drug) $135.88
- SOLOSEC (Drug) $118.73
- Myosure (Device) $100.00
- MYRISK (Device) $96.77
- Myosure Manual (Device) $88.40
- MyoSure manual (Device) $86.58
- CORVITE FE W QUATREFOLIC (Drug) $35.88
- MYFEMBREE (Drug) $16.35
- Balcoltra (Drug) $15.00
- CERVIDIL (Drug) $12.27
- Prenate Mini (Drug) $12.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Brooklyn
Miriam Cremer, Md, MD
Obstetrics & Gynecology — Payments: $284,535
Obstetrics & Gynecology $284,535
Dr. Kathleen Morrell Smalls, Md, Mph, MD, MPH
Obstetrics & Gynecology — Payments: $57,977
Obstetrics & Gynecology $57,977
Fadi Bashour, Md, MD
Obstetrics & Gynecology — Payments: $28,113
Obstetrics & Gynecology $28,113
Dr. Yi-Chun Lee
Obstetrics & Gynecology — Payments: $22,016
Obstetrics & Gynecology $22,016
Bahar Bybordi, Md, MD
Obstetrics & Gynecology — Payments: $9,655
Obstetrics & Gynecology $9,655
Dmitry Youshko, M.d, M.D
Obstetrics & Gynecology — Payments: $7,261
Obstetrics & Gynecology $7,261